10:41 AM EST - Titan Medical Inc. : Has completed its scheduled pre-clinical studies with its Enos™ robotic single access surgical system, performed in accordance with FDA’s good laboratory practice (GLP) regulations. GLP is a set of principles intended to assure the quality and integrity of non-clinical laboratory studies that are intended to support marketing permits for products regulated by government agencies. Titan Medical Inc.
shares T.TMD are trading up $0.15 at $2.18.
